Showing results (1241-1250 of 1,325) with videos related to
Sort By:
Pageof 133
Science (New York, N.Y.)|October 13, 2007
Energetic particles in the jovian magnetotailR L McNutt, D K Haggerty, M E Hill, et al.JACC. Heart Failure|December 14, 2020
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian OutbreakTomaso Bottio, Lorenzo Bagozzi, Alessandro Fiocco, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 2024
Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology)D Franceschini, D Greto, S Dicuonzo, et al.Neuro-Oncology|May 29, 2021
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIROSilvia Scoccianti, Emanuela Olmetto, Valentina Pinzi, et al.The Journal of Biological Chemistry|February 7, 2001
A G protein-coupled receptor for UDP-glucoseJ K Chambers, L E Macdonald, H M Sarau, et al.Physical Review Letters|July 24, 2020
Constraining Ion-Scale Heating and Spectral Energy Transfer in Observations of Plasma TurbulenceTrevor A Bowen, Alfred Mallet, Stuart D Bale, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E<sup>2</sup>-RADIatE OligoCare studySebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.Critical Reviews in Oncology/Hematology|January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacyStefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.Critical Reviews in Oncology/Hematology|January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicityStefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.Cancer Treatment Reviews|August 29, 2024
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical reviewAlberto Zambelli, Laura Cortesi, Mariangela Gaudio, et al.Pageof 133